Insider Transactions in Q3 2025 at Chromocell Therapeutics Corp (CHRO)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 01
2025
|
Ezra M Friedberg Director |
BUY
Conversion of derivative security
|
Indirect |
80,000
+50.0%
|
$800,000
$10.0 P/Share
|
Jul 01
2025
|
Todd C Davis Director |
BUY
Conversion of derivative security
|
Indirect |
1,500,000
+50.0%
|
$15,000,000
$10.0 P/Share
|
Jul 01
2025
|
Knuettel Francis Ii CFO, Treas & Secty |
BUY
Conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$100,000
$10.0 P/Share
|
Jul 01
2025
|
Ligand Pharmaceuticals Inc |
BUY
Conversion of derivative security
|
Direct |
1,500,000
+50.0%
|
$15,000,000
$10.0 P/Share
|